Up to down: BIA and Nuvonis to address ‘last frontier in bioprocessing’
BIA Separations has teamed with Nuvonis Technologies to help vaccine and cell therapy developers tackle the transition from upstream to downstream processing.
Archives for March 15, 2018
Novavax: Flu vaccine failings due to 'outdated' egg-based manufacturing
Egg adaptation is the biggest culprit in this year’s poor flu vaccine efficacy says Novavax, a firm developing a product based on recombinant protein nanoparticles.
Compugen licenses Selexis cell line tech
Compugen has selected Selexis’ SUREtechnology cell expression platform to generate high-performance research cell banks (RCBs) and support its antibody pipeline.